Good evening :)
Product logo

Tickertape - Financial freedom begins here

AllNewsEvents
  • Market
  • switcher
Spotlight
TMPVTMPV's JLR wholesale volumes surge 61% YoY in Q4

Wholesale volumes for the fourth quarter were 95,300 units (excluding the Chery Jaguar Land Rover China (CJLR) JV), down 14.5% year-on-year, reflecting ongoing challenges in certain markets and the planned wind down of legacy Jaguar models ahead of new Jaguar launch. Compared to the prior year, wholesale volumes for the fourth quarter were down in all markets, aside from Europe, which was up 4.1%. Volumes were lower in the UK (-23.1%), North America (-19.0%), China (-29.8%), Overseas (-7.9%) and MENA (-2.4%). The overall mix of Range Rover, Range Rover Sport and Defender models was 77.1% of total wholesale volumes in Q4 FY26, up from 66.3% in Q4 FY25 and up from 74.3% in the prior quarter. Retail sales for the fourth quarter of 92,700 units (including CJLR) were down 14.3% year-on-year but up 16.2% compared to Q3 FY26. Compared to the prior year, retail volumes for the fourth quarter were down in all markets, with the UK down 2.9%, North America down 13.8%, Europe down 6.4%, China down 34.6%, Overseas down 16.2% and MENA1 down 29.6%. On an annual basis, wholesale volumes for FY26 stood at 307,900 units, down 23.2% compared to FY25. Retail volumes for FY26 were 352,300 units, declining 17.8% year-on-year. For the full year, the combined mix of Range Rover, Range Rover Sport, and Defender models increased to 76.5%, up from 67.8% in the previous year. JLR will report its fourth quarter and full year results for the period ended 31 March 2026 in May 2026. Tata Motors (formerly TML Commercial Vehicles) is India's largest and a globally renowned manufacturer of utility vehicles, pick-ups, trucks, and buses. Its advanced powertrains, connected technologies, and intelligent fleet solutions support a wide range of applications'from last-mile delivery to public transport. The company reported consolidated net loss of Rs 3,486 crore in Q3 FY26 compared with net profit of Rs 5,406 crore in Q3 FY25. Revenue from operations fell 25.81% YoY to Rs 69,605 crore during the quarter. The counter rose 0.12% to end at Rs 303.25 on the BSE. The stock market will remain closed today, 4 April 2026, on account of Good Friday.

42 minutes agoCapital Market - Live
Corporate
SPVGLOBALSPV Global Trading EGM scheduled

SPV Global Trading announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 23 April 2026.

58 minutes agoCapital Market - Live
Spotlight
SURYODAYSuryoday SFB total deposits jumps 32% YoY in Q4 FY26

Gross advances jumped 29% YoY to Rs 13,201 crore in Q4 FY26, compared with Rs 10,251 crore in Q4 FY25. Disbursement surged 46% to Rs 3,077 crore in Q4 FY26, compared with Rs 2,101 crore in Q4 FY25. In Q4 FY26, retail deposits rose 3% YoY to Rs 12,003 crore while bulk deposits fell 2% YoY to Rs 1,955 crore. CASA stood at Rs 3,141 crore in Q4 FY26, up 42% compared with Rs 2,212 crore.CASA ratio stood at 22.5% in Q4 FY26 as against 20.9% in Q4 FY25. As of 31st March 2026, gross non-performing assets (GNPA) stood at Rs 864 crore, provision stood at Rs 317 crore, net non-performing assets (NNPA) stood at Rs 547 crore. Suryoday Small Finance Bank is a scheduled commercial bank. It commenced operations as an NBFC over a decade ago, with a clear focus on serving customers in the unbanked and underbanked segments and promoting financial inclusion. The bank has a wide presence across 15 states and Union Territories in India through its 710 banking outlets, with a strong presence in Maharashtra, Tamil Nadu, and Odisha. It offers a wide array of services to customers through its asset and liability products via multiple delivery channels. The bank reported a 9.79% increase in consolidated net profit to Rs 36.56 crore on 18.46% increase in total income to Rs 624.75 crore in Q3 FY26 over Q3 FY25. The counter fell 0.04% to settle at Rs 125.65 on the BSE. The stock market will remain closed today, 4 April 2026, on account of Good Friday.

1 hour agoCapital Market - Live
Spotlight
SHKS H Kelkar & Company reports 11.5% revenue growth in FY26 Q4 update

The company stated that gross margins remained stable on a sequential basis during the quarter, reflecting operational resilience amid a challenging environment. As of 31 March 2026, net debt stood at Rs 789 crore, primarily due to ongoing investments in capacity expansion and capability enhancement initiatives. The company noted that the operating environment remains fluid, impacted by inflationary pressures driven by geopolitical developments in the Middle East and evolving supply-side dynamics. It added that it continues to focus on ensuring uninterrupted supplies while taking prudent steps to safeguard margins and maintain operational stability. Inventory levels were reduced during the quarter, although sufficient coverage was maintained for commodities affected by the ongoing regional crisis. S H Kelkar & Company is engaged in the manufacture, supply and exports of fragrances and aroma ingredients. The company's consolidated net profit soared 86.4% to Rs 32.66 crore on 7.5% increase in net sales to Rs 581.13 crore in Q3 FY26 over Q3 FY25. The counter declined 2.68% to end at Rs 120 on the NSE.

2 hours agoCapital Market - Live
Spotlight
METROPOLISMetropolis Healthcare Q4 revenue climbs 23% YoY

Additionally, the company recorded robust growth across both its B2B and B2C channels, supported by a balanced combination of increased volumes and product mix improvements. B2C revenue grew by around 19% and B2B revenue by approximately 30% on YoY basis, driven by strong specialty growth and a higher B2B contribution in core diagnostics; additionally, TruHealth Wellness and specialty segments recorded growth of around 25% and approsimately 29%, respectively on Y-o-Y basis in Q4 FY26. Excluding the recent acquisitions of Core Diagnostics, DAPIC, Scientific and Ambika, revenue grew by around 14.5% YoY, largely on account of increased patient and test volume, and product mix. EBITDA margins for the quarter improved on a Y-o-Y basis, driven by operating leverage and efficiency gains. Metropolis Healthcare is India's second-largest pathology laboratory chain, offering diagnostic testing and related services across a nationwide network, with a strong presence in specialised and preventive healthcare diagnostics. On a consolidated basis, profit after tax (PAT) rose 33.7% YoY to Rs 42 crore in Q3FY26, compared with Rs 31 crore in Q3FY25. Revenue from operations increased 25.8% YoY to Rs 406 crore in Q3FY26, compared with Rs 323 crore in Q3FY25. The scrip shed 0.20% to end at Rs 422.95 on the BSE. The stock market will remain closed today, 4 April 2026, on account of Good Friday.

2 hours agoCapital Market - Live
Corporate
ECOHOTELSEco Hotels And Resorts to announce Quarterly Result

Eco Hotels And Resorts will hold a meeting of the Board of Directors of the Company on 10 April 2026.

2 hours agoCapital Market - Live
Corporate
ENERGYINFEnergy Infrastructure Trust to convene board meeting

Energy Infrastructure Trust will hold a meeting of the Board of Directors of the Company on 10 April 2026.

2 hours agoCapital Market - Live
Corporate
RISHABHRishabh Instruments allots 6,191 equity shares under ESOP

Rishabh Instruments has allotted 6,191 equity shares under ESOP on 03 April 2026. Post allotment, the paid up equity share capital has increased to 3,85,52,204 equity shares of Rs. 10/- each fully paid-up aggregating to Rs. 38,55,22,040/-.

2 hours agoCapital Market - Live
Corporate
HEGHEG to conduct EGM

HEG announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 5 May 2026.

2 hours agoCapital Market - Live
Corporate
DAVANGEREDavangere Sugar Company to hold EGM

Davangere Sugar Company announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 24 April 2026.

3 hours agoCapital Market - Live
Top gainers
  • Large Cap
  • switcher
STOCKSPRICECHANGE

4,303.904.79%

watchlist

1,402.203.53%

watchlist

1,441.502.63%

watchlist

522.252.45%

watchlist

13,109.002.36%

watchlist